Study S003416

Accuracy of Ultrasound Biomarkers for Assessing Eligibility and Response to Resmetirom Therapy Using MRI as the Reference Standard

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07860814
Study type: OBSERVATIONAL
Status: NOT_YET_RECRUITING
Enrollment: 524
Start: 2026-10
Primary completion: 2028-10
Lead sponsor: Radnet Management, Inc.
Conditions: Metabolic Dysfunction-steatohepatitis (MASH)
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Diagnostic performance of UDFF (ultrasound-derived fat fraction) [Enrollment Day 1 Baseline]
Diagnostic performance of Ultrasound pSWE (point shear wave elastography) [Enrollment Day 1 Baseline]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.